THC Therapeutics, Inc. engages in developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2007-12-07. The firm is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The company can also reduce the bacterial count of cannabis during the drying process. The firm also operates a portfolio of companies in genetics, cultivation, extraction, and distribution as well as specialty real estate and nutrients for commercial and hobby cannabis growers. These companies consist of Jefferson Soul, Kalix, NPK Industries, Harvest Food for Life, Shasta Properties Management, and Blue Sky Investments.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
07/31/2023
07/31/2022
07/31/2021
07/31/2020
07/31/2019
Revenue
0
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
Selling, General & Admin
0
0
1
0
1
24
Research & Development
--
--
--
--
--
--
Operating Expenses
0
0
1
0
1
24
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
0
0
-1
-1
-1
-23
Income Tax Expense
--
--
--
--
--
--
Net Income
0
0
-1
-1
-1
-23
Net Income Growth
--
-100%
0%
0%
-96%
283%
Shares Outstanding (Diluted)
38.33
32.8
33.24
23.65
16.55
13.37
Shares Change (YoY)
17%
-1%
41%
43%
24%
11%
EPS (Diluted)
-0.01
-0.01
-0.04
-0.07
-0.11
-1.74
EPS Growth
-5,967%
-74%
-43%
-32%
-93%
242%
Free Cash Flow
0
0
0
0
0
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
0%
0%
0%
0%
0%
0%
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
0
0
-1
0
-1
-24
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
0
0
-1
0
-1
-24
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
--
--
--
--
--
--
Follow-Up Questions
What are THC Therapeutics Inc's key financial statements?
According to the latest financial statement (Form-10K), THC Therapeutics Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for THCT?
THC Therapeutics Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is THC Therapeutics Inc's revenue broken down by segment or geography?
THC Therapeutics Inc largest revenue segment is Other, at a revenue of 664,276,000 in the most earnings release.For geography, Americas is the primary market for THC Therapeutics Inc, at a revenue of 1,732,385,000.
Is THC Therapeutics Inc profitable?
no, according to the latest financial statements, THC Therapeutics Inc has a net loss of $0
Does THC Therapeutics Inc have any liabilities?
yes, THC Therapeutics Inc has liability of 3
How many outstanding shares for THC Therapeutics Inc?
THC Therapeutics Inc has a total outstanding shares of 34.14